Detalhe da pesquisa
1.
Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.
Anticancer Drugs
; 35(2): 190-194, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018837
2.
Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors.
Anticancer Drugs
; 33(10): 1145-1149, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35946564
3.
The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.
Tuberk Toraks
; 70(2): 132-140, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785877
4.
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC Cancer
; 18(1): 598, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801465
5.
Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer.
Future Oncol
; 14(15): 1461-1467, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741392
6.
Vaccination in oncology practice and predictors.
Support Care Cancer
; 25(9): 2677-2682, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331981
7.
Docetaxel-induced pericardial effusion.
J Oncol Pharm Pract
; 23(5): 389-391, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27105899
8.
Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
Tumour Biol
; 36(6): 4279-85, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596702
9.
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.
Curr Med Res Opin
; : 1-21, 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809230
10.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Sci Rep
; 14(1): 5820, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461209
11.
The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
J Cancer Res Ther
; 19(5): 1248-1254, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787291
12.
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
J Cancer Res Clin Oncol
; 149(14): 13271-13277, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480524
13.
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
J Cancer Res Clin Oncol
; 149(2): 865-875, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381885
14.
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC.
Medicine (Baltimore)
; 101(34): e30188, 2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042659
15.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Medicine (Baltimore)
; 101(50): e32368, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550824
16.
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.
J Cancer Res Clin Oncol
; 148(12): 3547-3555, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689097
17.
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study.
J Cancer Res Clin Oncol
; 148(6): 1501-1508, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331582
18.
Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer.
Comb Chem High Throughput Screen
; 24(8): 1229-1235, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881660
19.
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
J Cancer Res Clin Oncol
; 147(7): 2145-2152, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33433657
20.
The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study.
J BUON
; 26(3): 819-829, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268941